SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001654954-17-008970
Filing Date
2017-09-29
Accepted
2017-09-29 16:49:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D opxa_sc13d.htm SC 13D 59486
  Complete submission text file 0001654954-17-008970.txt   61062
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81104 | Film No.: 171112040
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACER THERAPEUTICS INC. 222 THIRD STREET CAMBRIDGE MA 02142
Business Address
Schelling Chris (Filed by) CIK: 0001717241 (see all company filings)

Type: SC 13D